Interferon Alfa-2b With or Without Thalidomide in Treating Patients With Metastatic or Unresectable Kidney Cancer
Clinical trial NCT00005966 · COMPLETED
Trial details
- NCT number
- NCT00005966
- Sponsor
- Eastern Cooperative Oncology Group
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2000-10-01
- Primary completion
- 2006-03-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.